Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.

Abstract

A randomized, double-blind, placebo-controlled trial was conducted in eight hematologic units to determine the efficacy and safety of oral enoxacin for infection prevention in adult patients with acute nonlymphocytic leukemia. One hundred nineteen patients undergoing remission induction or consolidation chemotherapy were enrolled; 62 of them received… (More)

Topics

9 Figures and Tables

Cite this paper

@article{Talbot1993OralEF, title={Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.}, author={Guylaine Talbot and Peter A. Cassileth and Linda J. Paradiso and R Correa-Coronas and Lisa Bond}, journal={Antimicrobial agents and chemotherapy}, year={1993}, volume={37 3}, pages={474-82} }